Kyorin terminates tie-up with aTyr Pharma.
aTyr Pharma terminated a 2020 collaboration agreement with Kyorin Pharmaceutical effective July 30, 2026. The development partner exercised its termination rights, ending work on the licensed product.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day